|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||60.78 - 62.45|
|52-week range||60.78 - 84.00|
|PE ratio (TTM)||9.45|
|Earnings date||30 Apr 2018 - 4 May 2018|
|Forward dividend & yield||2.00 (3.24%)|
|1y target est||88.55|
Walgreens Boots Alliance (WBA), based in Deerfield, Illinois, is slated to release its 2Q18 financial results on March 28, 2018. Walgreens stock has followed a downward trend this year, falling 9% so far, like many peers. Refer to the final part of this series to learn about the company’s stock market performance this year.
When Heather Holland, a primary school teacher, went to collect her flu medicine at a local drugstore in Texas in January, she balked at the price. The pharmacist said she would have to pay $116 out of ...
CVS Health's (CVS) robust 2018 PBM selling season is an upside. We are also upbeat about the company's initiation of the crucial $69-billion acquisition of Aetna.
SuperValu (SVU) announced on Wednesday, March 14, 2018, that it has entered into three definitive agreements for the sale of 21 of its 38 Farm Fresh Food & Pharmacy stores to three grocery store chains. Harris Teeter (owned by Kroger) is buying ten stores, which include six in-store pharmacies and three fuel centers. The transactions have been unanimously approved by SuperValu’s board of directors and are subject to customary closing conditions.
The CVS Health (CVS)-Aetna deal has surfaced after Amazon, Berkshire Hathaway and JPMorgan Chase revealed their plans to form a joint venture.
Civitas Solutions (CIVI) is a leading provider of home and community-based health and human services to adults and children with intellectual or developmental disabilities, brain injury, and other catastrophic injuries and illnesses. In March 2018, of the four analysts covering Civitas Solutions, two analysts have given the stock a “strong buy” rating, and two analysts have given it a “buy” rating. The mean rating for the stock is 1.5 with a target price of $18.75.
Alphabet-backed (GOOGL) healthcare insurance startup Clover Health is looking to grow its revenues by 23.6% to $330 million in 2018, as it expands beyond its New Jersey initial footprint. In a recent interview with Bloomberg, Clover co-founder and chief executive officer Vivek Garipalli revealed that the startup suffered a $22-million loss in 2017. Clover is looking to control costs more efficiently this year, even as it invests in more growth.
Over 20 years, Brian Komoto built a thriving pharmacy in California’s Central Valley. Each day, his nurses would travel the vast agricultural region’s roads to help hepatitis C patients take a grueling ...
CVS reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.
The third-biggest corporate bond sale ever went off beautifully this past Tuesday. CVS Health (CVS) went to market to sell $40 billion of bonds to fund its proposed takeover of health insurer Aetna (AET), and was met with $120 billion worth of demand. Unsurprisingly, the bonds rallied as soon as they could be traded.
Cigna Corp.’s proposed deal for Express Scripts Holding Co. faces a drawn-out merger review as the Trump administration’s antitrust enforcers weigh the competitive effects of a wave of consolidation sweeping ...
Cigna's $67 billion Express Scripts deal gives the insurer the scale to match industry titans but also huge exposure to an area of health care that's under fire.
Health insurer Cigna will buy pharmacy benefit manager Express Scripts for $67 billion following the CVS-Aetna deal and Amazon's entry.
Big mergers in U.S. health care have rotated on their axis, with the nation’s biggest insurers and the companies that preside over customers’ access to high-priced drugs eyeing one another after deals ...
Health insurer Cigna Corp. is nearing a deal to buy Express Scripts Holding Co., according to people familiar with the matter. As of Wednesday, Express Scripts had a market value of $41 billion, meaning that with a typical premium, the transaction could be worth $50 billion or more. St. Louis-based Express Scripts is a pharmacy-benefit manager.